#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Byron Arana Email
Head Cutaneous Leishmaniasis Programme . Drugs for Neglected Diseases initiative (DNDi)
How to contact Byron Arana
Join and see Byron's contact info for free!Current Roles
Employees:
457Revenue:
$58.3MAbout
The Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patient-needs driven, not-for-profit research and development (R&D) organization that develops safe, effective, and affordable treatments for the millions of people across the world affected by neglected diseases, notably human African trypanosomiasis (sleeping sickness), leishmaniasis, Chagas disease, filarial infections, paediatric HIV, mycetoma, and hepatitis C. Launched in 2016 by the World Health Organization (WHO) and DNDi, the Global Antibiotic Research & Development Partnership (GARDP) aims to develop and deliver new treatments for bacterial infections where drug resistance is present or emerging, or for which inadequate treatment exists, while endeavouring to ensure sustainable access. GARDP is currently operating within DNDi, which provides its governance.Drugs for Neglected Diseases initiative (DNDi) Address
15 Chemin Camille-VidartGeneva, null